AQST - Aquestive Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.00
DETAILS
HIGH:
$12.00
LOW:
$6.00
MEDIAN:
$9.00
CONSENSUS:
$9.00
UPSIDE:
118.45%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 61.5% |
| EBIT Margin | -156.4% |
| EBITDA Margin | -155.1% |
| Operating Margin | -156.4% |
| Pretax Margin | -188.1% |
| Cont. Ops Margin | -188.1% |
| Net Margin | -188.1% |
| Bottom Line Margin | -188.1% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.14 |
| Quick Ratio | 3.01 |
| Solvency Ratio | -0.429 |
| Cash Ratio | 2.55 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-9.40
Peers avg: 28.4
|
| PEG Ratio | -0.19 |
| Forward PEG | -0.19 |
| Price/Book | -23.41 |
| Price/Sales | 17.69 |
| Price/FCF | -14.87 |
| Price/Op Cash Flow | -15.03 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.8194 |
| Debt/Equity | -3.9048 |
| Debt/Capital | 1.3443 |
| Long-Term Debt/Capital | 1.4114 |
| Financial Leverage | -4.77 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.52 |
| Operating Cash Flow Ratio | -1.101 |
| Operating Cash Flow/Sales | -117.7% |
| Free Cash Flow/Operating Cash Flow | 101.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -2.41 |
| Interest Coverage | -4.0731 |
| Short-Term Operating Cash Flow Coverage | -4.51 |
| Operating Cash Flow Coverage | -0.40 |
| Capital Expenditure Coverage | -93.30 |
| Dividend + Capital Expenditure Coverage | -93.30 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.37 |
| EPS | -0.687 |
| Debt/Share | 1.2179 |
| Cash/Share | 0.99 |
| Book Value/Share | -0.28 |
| Tangible BV/Share | -0.28 |
| Equity/Share | -0.28 |
| Operating Cash Flow/Share | -0.430 |
| Capital Expenditure/Share | 0.005 |
| FCF/Share | -0.434 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.203 |
| Price/Fair Value | -23.41 |
| Debt/Market Cap | 0.1613 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -11.55 |